Jefferies Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $674K | Buy |
8,341
+8,004
| +2,375% | +$719K | 0.01% | 933 |
|
|
2022
Q2 | $30.2K | Buy |
+337
| New | +$34.1K | ﹤0.01% | 1430 |
|
|
2022
Q1 | – | Sell |
-20,200
| Closed | -$2.09M | – | 1792 |
|
|
2021
Q4 | $2.09M | Buy |
20,200
+15,108
| +297% | +$1.75M | 0.01% | 780 |
|
|
2021
Q3 | $638K | Sell |
5,092
-1,451
| -22% | -$188K | ﹤0.01% | 1143 |
|
|
2021
Q2 | $812K | Buy |
6,543
+4,656
| +247% | +$585K | 0.01% | 1052 |
|
|
2021
Q1 | $223K | Sell |
1,887
-246
| -12% | -$28.8K | ﹤0.01% | 1325 |
|
|
2020
Q4 | $250K | Sell |
2,133
-4,870
| -70% | -$536K | ﹤0.01% | 1323 |
|
|
2020
Q3 | $728K | Sell |
7,003
-13,066
| -65% | -$1.31M | 0.01% | 894 |
|
|
2020
Q2 | $1.84K | Sell |
20,069
-65,732
| -77% | -$6.3M | 0.02% | 585 |
|
|
2020
Q1 | $7.74M | Buy |
85,801
+73,692
| +609% | +$7.84M | 0.09% | 201 |
|
|
2019
Q4 | $1.37M | Buy |
12,109
+11,193
| +1,222% | +$1.23M | 0.01% | 1273 |
|
|
2019
Q3 | $99K | Sell |
916
-42,217
| -98% | -$4.4M | ﹤0.01% | 2510 |
|
|
2019
Q2 | $4.2M | Sell |
43,133
-49,110
| -53% | -$4.48M | 0.03% | 550 |
|
|
2019
Q1 | $8.4M | Buy |
92,243
+29,755
| +48% | +$2.66M | 0.07% | 264 |
|
|
2018
Q4 | $5.68M | Buy |
62,488
+61,034
| +4,198% | +$5.7M | 0.05% | 368 |
|
|
2018
Q3 | $143K | Buy |
1,454
+979
| +206% | +$90.5K | ﹤0.01% | 2169 |
|
|
2018
Q2 | $41K | Hold |
475
| – | – | ﹤0.01% | 2205 |
|
|
2018
Q1 | $38K | Sell |
475
-47,923
| -99% | -$3.95M | ﹤0.01% | 2133 |
|
|
2017
Q4 | $3.91M | Sell |
48,398
-237,735
| -83% | -$19M | 0.02% | 660 |
|
|
2017
Q3 | $22.3M | Buy |
+286,133
| New | +$23.8M | 0.15% | 110 |
|
|
2017
Q2 | – | Sell |
-176,751
| Closed | -$14.9M | – | 2426 |
|
|
2017
Q1 | $14.2M | Sell |
176,751
-158,588
| -47% | -$12.4M | 0.11% | 177 |
|
|
2016
Q4 | $23.9M | Buy |
335,339
+297,550
| +787% | +$23.4M | 0.13% | 124 |
|
|
2016
Q3 | $3.27M | Buy |
37,789
+27,472
| +266% | +$2.39M | 0.02% | 706 |
|
|
2016
Q2 | $895K | Sell |
10,317
-72,865
| -88% | -$5.89M | ﹤0.01% | 1190 |
|
|
2016
Q1 | $6.24M | Buy |
83,182
+36,481
| +78% | +$2.75M | 0.04% | 412 |
|
|
2015
Q4 | $3.59M | Sell |
46,701
-63,069
| -57% | -$4.75M | 0.02% | 597 |
|
|
2015
Q3 | $7.35M | Buy |
109,770
+77,047
| +235% | +$5.67M | 0.04% | 343 |
|
|
2015
Q2 | $2.42M | Sell |
32,723
-6,165
| -16% | -$471K | 0.01% | 819 |
|
|
2015
Q1 | $3.03M | Sell |
38,888
-193,344
| -83% | -$14.7M | 0.02% | 601 |
|
|
2014
Q4 | $16.8M | Sell |
232,232
-42,128
| -15% | -$2.93M | 0.1% | 176 |
|
|
2014
Q3 | $17M | Buy |
274,360
+204,821
| +295% | +$13M | 0.12% | 157 |
|
|
2014
Q2 | $4.43M | Buy |
+69,539
| New | +$4.22M | 0.04% | 376 |
|
|
2014
Q1 | – | Sell |
-62,259
| Closed | -$3.57M | – | 2246 |
|
|
2013
Q4 | $3.57M | Buy |
62,259
+32,162
| +107% | +$1.82M | 0.02% | 400 |
|
|
2013
Q3 | $1.6M | Buy |
30,097
+14,108
| +88% | +$759K | 0.02% | 702 |
|
|
2013
Q2 | $823K | Buy |
+15,989
| New | +$790K | 0.01% | 857 |
|
Other funds holding MDT
Jefferies Group's MDT Position: Q3 2022 in Review
Jefferies Group increased its Medtronic (MDT) stake by 2,375% in Q3 2022, buying an estimated $719K and bringing the position to 8,341 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #933.
Jefferies Group first reported a position in MDT in Q2 2013 and has held it in 35 quarters since. The position peaked at $23.9M in Q4 2016. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Jefferies Group held 8,341 shares of Medtronic worth $674K as of Q3 2022.
- Jefferies Group bought 8,004 Medtronic shares in Q3 2022, an estimated $719K.
- Medtronic made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #933 holding.
- Jefferies Group first reported a position in Medtronic in Q2 2013 and has held it in 35 quarters since.
- Jefferies Group's Medtronic position peaked at $23.9M in Q4 2016.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.